Seroquel (Quetiapine) in Elderly Alzheimer's Patients: Safety Considerations

Quetiapine use in 80-year-olds with Alzheimer's requires careful risk-benefit analysis by a geriatric psychiatrist or experienced clinician.

Key Risks

• Increased sensitivity: Sedation, orthostatic hypotension, falls, confusion, pneumonia, dehydration.
• Cognitive worsening: Anticholinergic burden may exacerbate dementia.
• Drug interactions: Polypharmacy common; CYP3A4 interactions.
• Metabolic effects: Weight gain, dyslipidemia, glucose dysregulation.
• Stroke/mortality warning: FDA boxed warning for increased mortality in elderly dementia-related psychosis.

Guiding Principles

• Non-pharmacologic measures first (environment, routine, redirection).
• If needed, start low (12.5–25 mg), go slow.
• Regular reassessment: efficacy, side effects, necessity.
• Attempt taper/discontinuation if no clear benefit.

Decision must be individualized, documented, and monitored.